RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-97

I have answered your question. Twice now.

So again, so others can see it in response to your response, the reason is the many many people are being infected. So, with the large amount of infections, there will be some who die.

Because no treatment works 100% in all cases. but, the percentage who do die compared to those who get infected are an extremely small group, particularly for those who are vaccinated. The percentage has dropped continuously over the journey.

And importantly, as new better and cheaper treatments are developed and approved at warp speed, the mortality rate will improve further.

But, now I think it’s up to you to explain why, if we have a miracle cure waiting to save the world, did Novartis walk away from this fantastic treatment? Hope you can answer this without bolding to highlight the important question.